ClinConnect ClinConnect Logo
Search / Trial NCT07120802

Better4All Personalized Intervention Pilot Study

Launched by HAROKOPIO UNIVERSITY · Aug 6, 2025

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

Weight Management Polygenic Risk Score Artificial Intelligence Personalized Intervention Obesity Randomized Controlled Trial

ClinConnect Summary

This clinical trial, called the Better4All Personalized Intervention Pilot Study, is focused on preventing obesity by using a special program tailored to each person’s lifestyle. The study uses smartwatches and a mobile app to track daily habits like eating, exercise, sleep, and the environment around you (such as how close you are to parks). The goal is to see if this technology and the personalized advice it offers are easy to use and helpful before testing it on a larger scale.

Adults aged 18 to 65 who live in one of the seven participating countries (Cyprus, France, Greece, Poland, Portugal, Spain, or Sweden) may be eligible. Participants should either have a normal weight or be overweight/obese and need to be comfortable using a smartwatch and an Android smartphone app. During the three-week study, participants will wear the smartwatch and use the app to record their daily behaviors. Healthcare providers will also try out the system to help improve it. This pilot study will help the researchers make the program better and easier to use for everyone before it is offered to more people.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age: Participants aged 18-65 years to represent the adult general population.
  • * Body Mass Index (BMI):
  • Overweight or obesity group: BMI ≥ 25 kg/m².
  • Normal weight group: BMI 18.5-24.9 kg/m².
  • * Technology Use:
  • Willingness and ability to use wearable devices and an Android mobile application for the duration of the study.
  • Owning a smartphone device with the Android operating system.
  • Eating utensil technique: dominant hand gestures that correspond to handling of food via a fork or a spoon.
  • Language Proficiency: Ability to read and understand the language in which the mobile app and study materials are provided.
  • Consent: Willing to provide informed consent to participate in the study.
  • Residency: Must be a resident of one of the seven participating countries.
  • Availability: Able to participate for the full three-week duration of the study and comply with the study protocol.
  • Exclusion Criteria:
  • Health Conditions: Pregnant or breastfeeding women, as they might have different lifestyle behaviours or health needs.
  • Physical Limitations: Any physical or mental condition that would prevent the participant from using the wearable device or mobile application as intended.
  • Eating utensil technique: eating food with chopsticks on a daily or regular basis.
  • Technical Incompatibility: Individuals who do not own a compatible smartphone or are unable to use the provided wearable devices for technical reasons.

About Harokopio University

Harokopio University, located in Athens, Greece, is a prominent academic institution dedicated to advancing research and education in various fields, including health sciences and nutrition. With a strong commitment to interdisciplinary collaboration, the university actively engages in clinical trials aimed at exploring innovative solutions to pressing health challenges. Through its rigorous research programs and partnerships with healthcare professionals, Harokopio University strives to contribute valuable insights to the scientific community and improve public health outcomes.

Locations

Huddinge, , Sweden

Nicosia, , Cyprus

Villeurbanne, , France

Athens, Aticca, Greece

Lisboa, , Portugal

Pamplona, Navarra, Spain

Wrocław, , Poland

Patients applied

0 patients applied

Trial Officials

Yannis Manios, Professor

Principal Investigator

Department of Nutrition and Dietetics, School of Health Science & Education, Harokopio University, Athens, Greece

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported